1) Shreve PD, Anzai Y, Wahl RL : Pitfalls in oncologic diagnosis with FDG PET imaging : physiologic and benign variants. Radiographics 19 : 61─77, 1999
2) Lerman H, Metser U, Grisaru D, et al : Normal and abnormal 18F─FDG endometrial and ovarian uptake in pre─and postmenopausal patients : assessment by PET/CT. J Nucl Med 45 : 266─271, 2004
3) Nishizawa S, Inubushi M, Okada H : Physiological 18F─FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med 32 : 549─556, 2005
4) Rose PG, Adler LP, Rodriguez M, et al : Positron emission tomography for evaluating para─aortic nodal metastasis in locally advanced cervical cancer before surgical staging : a surgicopathologic study. J Clin Oncol 17 : 41─45, 1999
5) Yeh LS, Hung YC, Shen YY, et al : Detecting para─aortic lymph nodal metastasis by positron emission tomography of 18F─fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings. Oncol Rep 9 : 1289─1292, 2002
6) Lin WC, Hung YC, Yeh LS, et al : Usefulness of(18)F─fluorodeoxyglucose positron emission tomography to detect para─aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 89 : 73─76, 2003
7) Reinhardt MJ, Ehritt─Braun C, Vogelgesang D, et al : Metastatic lymph nodes in patients with cervical cancer : detection with MR imaging and FDG PET. Radiology 218 : 776─782, 2001
8) Belhocine T, Thille A, Fridman V, et al : Contribution of whole─body 18FDG PET imaging in the management of cervical cancer. Gynecol Oncol 87 : 90─97, 2002
9) Nakamoto Y, Eisbruch A, Achtyes ED, et al : Prognostic value of positron emission tomography using F─18─fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. Gynecol Oncol 84 : 289─295, 2002
10) Sun SS, Chen TC, Yen RF, et al : Value of whole body 18F─fluoro─2─deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Anticancer Res 21 : 2957─2961, 2001
11) Havrilesky LJ, Wong TZ, Secord AA, et al : The role of PET scanning in the detection of recurrent cervical cancer. Gynecol Oncol 90 : 186─190, 2003
12) Ryu SY, Kim MH, Choi SC, et al : Detection of early recurrence with(18)F─FDG PET in patients with cervical cancer. J Nucl Med 44 : 347─352, 2003
13) Grigsby PW, Siegel BA, Dehdashti F, et al : Posttherapy surveillance monitoring of cervical cancer by FDG─PET. Int J Radiat Oncol Biol Phys 55 : 907─913, 2003
14) Horowitz NS, Dehdashti F, Herzog TJ, et al : Prospective evaluation of FDG─PET for detecting pelvic and para─aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 95 : 546─551, 2004
15) Belhocine T, De Barsy C, Hustinx R, et al : Usefulness of(18)F─FDG PET in the post─therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 29 : 1132─1139, 2002
16) Saga T, Higashi T, Ishimori T, et al : Clinical value of FDG─PET in the follow up of post─operative patients with endometrial cancer. Ann Nucl Med 17 : 197─203, 2003
17) Nakamoto Y, Saga T, Ishimori T, et al : Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol 176 : 1449─1454, 2001
18) Zimny M, Siggelkow W, Schroder W, et al : 2─[Fluorine─18]─fluoro─2─deoxy─D─glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 83 : 310─315, 2001
19) Yen RF, Sun SS, Shen YY, et al : Whole body positron emission tomography with 18F─fluoro─2─deoxyglucose for the detection of recurrent ovarian cancer. Anticancer Res 21 : 3691─3694, 2001
20) Torizuka T, Nobezawa S, Kanno T, et al : Ovarian cancer recurrence : role of whole─body positron emission tomography using 2─[fluorine─18]─fluoro─2─deoxy─D─glucose. Eur J Nucl Med Mol Imaging 29 : 797─803, 2002
21) Cho SM, Ha HK, Byun JY, et al : Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR Am J Roentgenol 179 : 391─395, 2002
22) Kim S, Chung JK, Kang SB, et al :[18F]FDG PET as a substitute for second─look laparotomy in patients with advanced ovarian carcinoma. Eur J Nucl Med Mol Imaging 31 : 196─201, 2004
23) Patel PV, Cohade C, Chin BB : PET─CT localizes previously undetectable metastatic lesions in recurrent fallopian tube carcinoma. Gynecol Oncol 87 : 323─326, 2002
24) Tsai CC, Tsai CS, Ng KK, et al : The impact of image fusion in resolving discrepant findings between FDG─PET and MRI/CT in patients with gynaecological cancers. Eur J Nucl Med Mol Imaging 30 : 1674─1683, 2003
25) Barranger E, Kerrou K, Petegnief Y, et al : Laparoscopic resection of occult metastasis using the combination of FDG─positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer. Gynecol Oncol 96 : 241─244, 2005